Results 101 to 110 of about 19,354 (307)

Very Early and Unusual Aortic Bioprosthetic Valve Deterioration 9 Months after Implantation

Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2020
Every component of valvular bioprostheses is prone to variable structural deterioration secondary to multifactorial etiopathogenesis. Calcific degeneration is the most common phenomenon.
Madhu Shukla, Vishwas Mohan, Jagdish C. Mohan   +2 more
doaj   +1 more source

Left Bundle Branch Pacing in a Pediatric Patient With Tricuspid Valve Replacement for a Complex Ebstein Anomaly

Annals of Noninvasive Electrocardiology, Volume 30, Issue 2, March 2025.
This paper presents a unique case of successful implementation of left bundle branch pacing (LBBP) in a pediatric patient with third‐degree atrioventricular block following tricuspid valve replacement for a complex Ebstein anomaly. The procedure was performed under real‐time recording technique, and resulted in the resolution of the patient's symptoms.
Di Tian, Longfu Jiang, Jiabo Shen
wiley   +1 more source

Changes in patient characteristics and procedural measures over a 10-year period in aortic valve-in-valve procedures for degenerated surgical bioprostheses

Frontiers in Cardiovascular Medicine
Graphical AbstractThis single-center study investigates changes in patient characteristics and procedural measures over a period of 10 years in aortic valve-in-valve procedures for treatment of degenerated surgical bioprostheses.
Tim Knochenhauer, Till J. Demal, Till J. Demal, Oliver D. Bhadra, Sebastian Ludwig, Nils Arne Sörensen, Ina von der Heide, Laura Hannen, David Grundmann, Lisa Voigtländer-Buschmann, Lara Waldschmidt, Johannes Schirmer, Simon Pecha, Evaldas Girdauskas, Evaldas Girdauskas, Stefan Blankenberg, Stefan Blankenberg, Hermann Reichenspurner, Hermann Reichenspurner, Niklas Schofer, Andreas Schaefer   +20 more
doaj   +1 more source

Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis [PDF]

, 2017
Objective: The ATS 3f Enable® Bioprosthesis is a self-expanding valve with a tubular design that allows for decreased leaflet stress and preservation of aortic sinuses. We report the midterm results of a prospective, multicenter clinical study evaluating
Bartus, Krzysztof, Carrel, Thierry, Eckstein, Friedrich S., Kapelak, Boguslaw, Martens, Sven, Sadowski, Jerzy, Schlensak, Christian, Sievers, Hans-Hinrich   +7 more
core  

Initial experience of a large, self-expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters' registry. [PDF]

, 2019
OBJECTIVES: The UK & Ireland Implanters' registry is a multicenter registry which reports on real-world experience with novel transcatheter heart valves. BACKGROUND: The 34 mm Evolut R transcatheter aortic valve is a self-expanding and fully recapturable
Abdelaziz, HK, Anderson, R, Blackman, DJ, Brecker, SJ, Brennan, PF, Buch, MH, Chandrala, P, Chowdhary, S, Cunnington, MS, Dalby, M, Deegan, L, Demir, OM, Dorman, S, Doshi, S, Dowling, C, Doyle, N, Firoozi, S, Frame, A, Ghada, MW, Grech, E, Hall, I, Hildick-Smith, D, Kabir, T, Kashyap, MN, Kennon, S, Kontoprias, K, Kovac, J, Levy, R, Malik, IS, Malkin, CJ, Manoharan, G, Martin, N, Mercanti, F, More, R, Mullen, M, Mylotte, D, Neville, M, Neylon, A, Owens, CG, Panoulas, V, Rajathurai, T, Rampat, R, Roberts, D, Ruparelia, N, Saraf, S, Sen, S, Spence, MS, Tapp, L, Uren, NG, Wiper, A   +49 more
core   +1 more source

Bioprostheses and Mechanical Prostheses for Aortic Valve Replacement in Patients Aged 50 to 65 Years Offer Similar Long-Term Survival Rates

Journal of Cardiovascular Development and Disease
Background: Aortic valve replacement (AVR) is the definitive therapy for patients with severe aortic valve stenosis (AoS). The aim of this work is to compare the effect of a mechanical prosthesis (MP) and a bioprosthesis (BP) on the survival of patients ...
Tomáš Toporcer, Štefan Lukačín, Andrea Kraus, Marián Homola, Anton Bereš, Michal Trebišovský, Denis Radótzy, Vilém Rohn, Adrián Kolesár   +8 more
doaj   +1 more source

Safety, effectiveness and haemodynamic performance of a new stented aortic valve bioprosthesis†

European Journal of Cardio-Thoracic Surgery, 2017
OBJECTIVES We assessed the safety, effectiveness and haemodynamic performance of a new bovine stented aortic valve bioprosthesis (Avalus™). METHODS The PERIGON Pivotal Trial is a prospective, non‐randomized, multicentre study.
R. Klautz, Pieter A. Kappetein, R. Lange, F. Dagenais, L. Labrousse, V. Bapat, M. Moront, M. Misfeld, Cathy Zeng, J. Sabik   +9 more
semanticscholar   +1 more source

Valve replacement in octogenarians: increased early mortality but good long-term result [PDF]

, 2017
Between January 1983 and December 1990, 20 patients aged 80 years or older underwent valvular surgery. The patients' ages varied from 80 to 87 years (mean, 82 ± 1.5 years).
BAUER, E., CARREL, T., JENNI, R., LASKE, A., PASIC, M., TURINA, J., TURINA, M., VON SEGESSER, L.   +7 more
core  

Thrombocytopenia After Aortic Valve Replacement: Comparison Between Sutureless Perceval S Valve and Perimount Magna Ease Bioprosthesis

Brazilian Journal of Cardiovascular Surgery, 2018
Introduction The incidence of postoperative thrombocytopenia after aortic valve replacement (AVR) with the Perceval S Sutureless bioprosthesis remains unclear. The aim of this study was to report thrombocytopenia associated with the use of sutureless AVR.
S. S. Mujtaba, S. Ledingham, A. Shah, S. Schueler, S. Clark, T. Pillay   +5 more
semanticscholar   +1 more source

Comparison of a novel mechanical valve versus stented bioprosthetic valves for isolated mitral valve replacement in patients older than 65 yearsCentral MessagePerspective

JTCVS Open
Objective: To compare early and long-term clinical outcomes of bioprosthetic versus mechanical (On-X) mitral valve replacement (MVR) in patients aged 65 years and older.
Antonio Piperata, MD, PhD, Carlo Mariani, MD, PhD, Giacomo Murana, MD, PhD, Elio Fabbri, PhD, Paola Rucci, PhD, Maria Francesca Scuppa, MD, Filippo Londi, MD, Edoardo Bianco, MD, Benedetta Guerrini, MD, Ivan Tammaro, MD, Ludovica Fabiani, MD, Margherita Careddu, MD, Marta Bellomare, MD, Silvia Snaidero, MD, Riccardo Nania, MD, Sabrina Castagnini, MD, Marta Di Carlo, MD, Valentina Orioli, MD, Gianluca Folesani, MD, Davide Pacini, MD, PhD   +19 more
doaj   +1 more source